AdaptHealth Swings to a $133.9M Q2 Loss on a $144.2M Goodwill Impairment, Cuts Guidance, and Launches Restructuring
AHCO is trading near its 52-week low of $6.14 (9.6% above the low) on elevated volume (11× avg).
Summary
AdaptHealth reported a $133.9M Q2 net loss after a $144.2M goodwill impairment, cut FY2026 guidance, and announced a restructuring plan. The company is selling its Diabetes Health business for $235M and disclosed a material cybersecurity incident.
Key Events · Earnings and Guidance · AHCO
-
Q2 Net Loss of $133.9M
Net loss attributable to AdaptHealth Corp. was $133.9M, or $0.99 per share, compared to net income of $14.7M a year ago. The loss was driven by a $144.2M non-cash goodwill impairment charge in the Respiratory Health and Wellness at Home segments.
-
$144.2M Goodwill Impairment
A quantitative impairment test triggered by the planned divestiture of the Diabetes Health business and revised financial projections resulted in a $144.2M non-cash charge, wiping out goodwill in two reporting units.
-
FY2026 Guidance Cut
The company reduced its full-year Adjusted EBITDA guidance by $6M (implied by the prior 8-K on August 4, 2026), reflecting weaker operating performance and higher costs.
-
Restructuring Plan Announced
A cost-savings plan including headcount reductions and a business wind-down is expected to generate $26.8M in annual savings, with total costs of approximately $7.0M. $6.1M in charges were recognized in Q2.
Analysis · AHCO · Industrial Applications And Services
A massive non-cash goodwill impairment in the Respiratory Health and Wellness at Home segments drove AdaptHealth to a deep Q2 loss, reflecting deteriorating fair values. The company also cut full-year Adjusted EBITDA guidance, launched a restructuring plan expected to save $26.8M annually, and is selling its Diabetes Health business for $235M to pay down debt. Adding legal overhang, a material cybersecurity breach and multiple government investigations were disclosed. The quarter marks a sharp deterioration in profitability and a strategic pivot to stabilize the balance sheet.
At the time of this filing, AHCO was trading at $6.73 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $912.9M. The 52-week trading range was $6.14 to $13.43. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.